303
Views
0
CrossRef citations to date
0
Altmetric
Articles

Structural and molecular modelling studies of antimelanogenic piper-amide TRPM1 antagonists

, , , & ORCID Icon
Pages 195-207 | Received 18 Dec 2018, Published online: 18 Feb 2019
 

ABSTRACT

Piper-amides exhibit diverse biological activities, including antimelanogenic effects. In our previous studies, we identified a potent piper-amide derivative that inhibited melanogenesis via the TRPM1 calcium channel. Despite its potential as a therapeutic target, the three-dimensional structure of TRPM1 is still not available. Thus, structure-guided compound design and the discovery of novel inhibitors of melanogenesis have been limited. In the present study, a series of computational methods, including homology modelling, docking, molecular dynamics simulation and field-based pharmacophore modelling, were integrated to explore the structural features of natural piper-amide-like compounds related to the TRPM1 target. These studies suggested the binding mode and provided a 3D pharmacophore model of the ligands, which can be helpful in understanding the TRPM1–ligand interactions at the molecular level and in designing potent antagonists of TRPM1.

Disclosure statement

No potential conflict of interest was reported by the authors.

Supplemental Material

Supplementary material for this article can be accessed at: https://doi.org/10.1080/1062936X.2019.1574894

Additional information

Funding

This work was supported by the Mid-Career Researcher Program [NRF-2016R1A2A1A05005375] of the National Research Foundation (NRF) grant funded by the Korea government (MSIP).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.